Banka BioLoo Approves Grant of 2,000 ESOPs at Face Value
Banka BioLoo Ltd 路 Others (Uncategorized) 路 16 Oct 2026, 5:31 pm
Banka BioLoo Approves Grant of 2,000 ESOPs at Face Value The Nomination and Remuneration Committee of Banka BioLoo Limited approved the grant of 2,000 stock options under its Employees Stock Option Plan 2023 on 16th Oct'26. Each option is convertible into one equity share of face value Rs. 10 at an exercise price of Rs. 10 per share. The options vest equally at 25% annually across 12, 24, 36, and 48 months from the grant date, with an exercise window of two years from respective vesting dates. Allotted shares carry no lock-in restrictions.
Original exchange filing (PDF)
More announcements from Banka BioLoo Ltd
- Banka BioLoo Limited has informed the Exchange regarding 'ESOP Trading approval for 5000 equity shares'. 路 14 Nov 2026
- Unaudited financial results for the quarter and half year ended 30 September 2026. 路 13 Nov 2026
- Banka BioLoo Limited has informed the Exchange regarding 'Financial results for the quarter and half year ended 30 September 2026'. 路 12 Nov 2026
- Banka BioLoo Limited has informed the Exchange about Investor Presentation 路 12 Nov 2026
- Banka BioLoo Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 12 Nov 2026
- Significant movement in price has been observed in Banka BioLoo Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Banka BioLoo Limited has submitted their response. 路 10 Nov 2026
- Significant movement in price has been observed in Banka BioLoo Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. 路 10 Nov 2026
- BANKA BIOLOO LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 12 Nov 2026
